Osaic Holdings
VRTX icon

Osaic Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Osaic Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.6M Buy
43,972
+220
+0.5% +$103K 0.03% 584
2025
Q4 		$19.8M Sell
43,752
-40,498
-48% -$17.5M 0.03% 582
2025
Q3 		$33M Buy
84,250
+33,922
+67% +$14.2M 0.05% 426
2025
Q2 		$22.9M Buy
50,328
+16,779
+50% +$7.73M 0.04% 452
2025
Q1 		$16.3M Sell
33,549
-15,754
-32% -$7.34M 0.04% 489
2024
Q4 		$15.2M Sell
49,303
-143
-0.3% -$66.3K 0.03% 490
2024
Q3 		$23M Sell
49,446
-3,649
-7% -$1.75M 0.05% 362
2024
Q2 		$24.9M Sell
53,095
-7,464
-12% -$3.24M 0.06% 337
2024
Q1 		$25.3M Sell
60,559
-35,387
-37% -$15M 0.06% 337
2023
Q4 		$39M Sell
95,946
-20,228
-17% -$7.47M 0.07% 262
2023
Q3 		$40.4M Buy
116,174
+51,198
+79% +$17.9M 0.06% 305
2023
Q2 		$22.8M Buy
64,976
+4,824
+8% +$1.63M 0.04% 413
2023
Q1 		$19M Buy
60,152
+2,380
+4% +$714K 0.04% 472
2022
Q4 		$16.7M Sell
57,772
-4,952
-8% -$1.51M 0.03% 500
2022
Q3 		$18.2M Buy
62,724
+2,665
+4% +$767K 0.04% 408
2022
Q2 		$16.9M Buy
60,059
+5,159
+9% +$1.38M 0.04% 441
2022
Q1 		$14.1M Buy
54,900
+6,371
+13% +$1.51M 0.03% 582
2021
Q4 		$10.7M Buy
48,529
+15,222
+46% +$2.96M 0.02% 712
2021
Q3 		$6.04M Sell
33,307
-4,083
-11% -$797K 0.01% 947
2021
Q2 		$7.54M Sell
37,390
-4,539
-11% -$949K 0.02% 809
2021
Q1 		$9M Buy
41,929
+6,384
+18% +$1.4M 0.02% 642
2020
Q4 		$8.4M Buy
35,545
+3,312
+10% +$760K 0.02% 589
2020
Q3 		$8.81M Sell
32,233
-12,541
-28% -$3.46M 0.03% 510
2020
Q2 		$13M Buy
44,774
+3,359
+8% +$911K 0.04% 352
2020
Q1 		$7.05M Buy
+41,415
New +$9.5M 0.03% 485

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Osaic Holdings's VRTX Position: Q1 2026 in Review

Osaic Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 0.5% in Q1 2026, buying an estimated $103K and bringing the position to 43,972 shares worth $19.6M. The position accounts for 0.03% of the portfolio, ranked #584.

Osaic Holdings first reported a position in VRTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $40.4M in Q3 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Osaic Holdings held 43,972 shares of Vertex Pharmaceuticals worth $19.6M as of Q1 2026.
  • Osaic Holdings bought 220 Vertex Pharmaceuticals shares in Q1 2026, an estimated $103K.
  • Vertex Pharmaceuticals made up 0.03% of Osaic Holdings's portfolio in Q1 2026, its #584 holding.
  • Osaic Holdings first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Vertex Pharmaceuticals position peaked at $40.4M in Q3 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.